Skip to main content

Table 3 The incidence of major complications after TIPS treatment

From: Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment

 

HE

Re-bleeding/Bleeding

Total

267/704 (37.9%)

109/704 (15.5%)

 Variceal bleeding

208/581 (35.8%)

81/581 (13.9%)

 Refractory ascites

31/72 (43.1%)

6/72 (8.3%)

 Variceal bleeding and refractory ascites

28/51 (54.9%) #

22/51 (43.1%) ##

Child-Pugh classification

  

 A

83/219 (37.8%)

37/219 (16.9%)

 B

142/421 (33.7%)

61/421 (14.5%)

 C

42/64 (65.6%) ##

11/64 (17.2%)

Type of stent

  

 Uncovered stent (n = 130)

56/130 (43.1%)

17/130 (13.1%)

  Diameter of stent = 8 mm (n = 47)

17/47 (36.1%)

5/47 (10.6%)

  Diameter of stent = 10 mm (n = 83)

39/83 (47.0%)

12/83 (14.5%)

 Covered stent (n = 574)

211/574 (36.8%)

92/574 (16.0%)

  Diameter of stent = 6 mm (n = 94)

6/94 (6.4%) ###

14/94 (14.9%)

  Diameter of stent = 7 mm (n = 178)

67/178 (37.6%)

31/178 (17.4%)

  Diameter of stent = 8 mm (n = 302)

138/302 (45.7%)

47/302 (15.6%)

  1. #P < 0.05, ## P < 0.01, and ### P < 0.01 compared with other groups, Chi-squared test